AirSculpt Stock (NASDAQ:AIRS)
Previous Close
$4.76
52W Range
$2.92 - $9.20
50D Avg
$5.97
200D Avg
$5.09
Market Cap
$275.52M
Avg Vol (3M)
$247.69K
Beta
1.62
Div Yield
-
AIRS Company Profile
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of March 10, 2022, it operated 19 centers across 15 states. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
AIRS Performance
Peer Comparison
Ticker | Company |
---|---|
SEM | Select Medical Holdings Corporation |
EHC | Encompass Health Corporation |
ACHC | Acadia Healthcare Company, Inc. |
AMED | Amedisys, Inc. |
ADUS | Addus HomeCare Corporation |
SGRY | Surgery Partners, Inc. |
INNV | InnovAge Holding Corp. |
UHS | Universal Health Services, Inc. |
TOI | The Oncology Institute, Inc. |
EHAB | Enhabit, Inc. |
AVAH | Aveanna Healthcare Holdings Inc. |
ENSG | The Ensign Group, Inc. |
PNTG | The Pennant Group, Inc. |